Comparison of the effect of denosumab and alendronate on BMD and biochemical markers of bone turnover in postmenopausal women with low bone mass: a randomized, blinded, phase 3 trial (Q46393065)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Comparison of the effect of denosumab and alendronate on BMD and biochemical markers of bone turnover in postmenopausal women with low bone mass: a randomized, blinded, phase 3 trial |
scientific article |
Statements
1 reference
Comparison of the effect of denosumab and alendronate on BMD and biochemical markers of bone turnover in postmenopausal women with low bone mass: a randomized, blinded, phase 3 trial (English)
1 reference
Jacques P Brown
1 reference
Richard L Prince
1 reference
Chad Deal
1 reference
Robert R Recker
1 reference
Douglas P Kiel
1 reference
Luiz H de Gregorio
1 reference
Peyman Hadji
1 reference
Lorenz C Hofbauer
1 reference
Jose M Alvaro-Gracia
1 reference
Huei Wang
1 reference
Matthew Austin
1 reference
Rachel B Wagman
1 reference
Richard Newmark
1 reference
Cesar Libanati
1 reference
Javier San Martin
1 reference
Henry G Bone
1 reference
1 January 2009
1 reference
24
1 reference
1
1 reference
153-161
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference